| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
LIVING CELL TECHNOLOGIES LIMITED (LCT)
Stock Code: LCT
Listing Date: 2004-09-01 00:00:00
Website: http://www.lctglobal.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Development of cell based technology for treatment of Huntington's disease, Haemophilia and Diabetes.
Address:
255 George Street, Level 5
SYDNEY
NSW 2000
Phone: (02) 9252 1933
Fax: (02) 9252 2487
Executives & Directors
Mr Simon O'Loughlin, Chairman
Dr Robert Caspari, Executive Director, CEO
Mr Robert Elliott, Executive Director
Mr David Collinson, Non Exec. Director
Mr Laurie Hunter, Independent Director
Dr David Brookes, Independent Director
Dr Paul Tan, Chief Op. Officer
Mr Nick Geddes, Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
LCT - Australian Biotechnology Summit Presentation - Dr Paul Tan, Chief Operating Officer
|
|
Thu, 31 Jul 2008 12:30PM |
|
LCT - LCT Expands Management Team - Dr Robert Caspari, CEO
|
|
Thu, 31 Jul 2008 10:30AM |
|
LCT - Living Cell Technologies Granted Diabetes Patent in the US - Mr David Collinson, CEO & Executive Director
|
|
Fri, 7 Jul 2006 02:00PM |
| Annual General Meeting | Thu, 6 Nov 2008 01:30PM |
|
| Full Year Results | Tue, 7 Oct 2008 | |
| Interim Results | Fri, 29 Feb 2008 | |
| Annual General Meeting | Wed, 28 Nov 2007 | |
| Full Year Results | Fri, 31 Aug 2007 | |
| Interim Results | Wed, 28 Feb 2007 | |
| Full Year Results | Wed, 13 Sep 2006 | |
| Interim Results | Thu, 16 Mar 2006 | |
| Annual General Meeting | Wed, 16 Nov 2005 04:30PM |
LIVING CELL TECHNOLOGIES LIMITED (LCT)
| Annual General Meeting Update | Thu, 6 Nov 2008 |
| Annual General Meeting Results | Thu, 6 Nov 2008 |
| Appendix 4C - quarterly | Fri, 31 Oct 2008 |
| LCT Expands Production Facility | Thu, 23 Oct 2008 |
| Amended Appendix 3B | Wed, 22 Oct 2008 |
| LCT Receives Ministers Approval for NZ Trial | Tue, 21 Oct 2008 |
| Notice of Annual General Meeting | Tue, 7 Oct 2008 |
| Annual Report to Shareholders | Tue, 7 Oct 2008 |
| Audited Financial Report | Tue, 23 Sep 2008 |
| Preliminary Final Report | Fri, 29 Aug 2008 |
| Appendix 4C - quarterly | Thu, 31 Jul 2008 |
| LCT Expands Management Team | Tue, 29 Jul 2008 |
| Change of Director`s Interest Notice | Wed, 23 Jul 2008 |
| LCT Reports Clinical Benefits | Tue, 22 Jul 2008 |
| LCT Hosts Diabetes Seminar of World Leaders | Thu, 17 Jul 2008 |
| Quarterly Newsletter | Mon, 14 Jul 2008 |
| LCT Informed of Progress for Diabetes Clinical Trial | Thu, 26 Jun 2008 |
| LCT Confirms Insulin Delivery from Implants | Wed, 25 Jun 2008 |
| Appendix 3B | Fri, 20 Jun 2008 |
| LCT Expands Diabetes Clinical Trial | Thu, 5 Jun 2008 |
| Appendix 3Y Change of Director`s Interest Notice | Wed, 4 Jun 2008 |
| LCT lists on International OTCQX | Tue, 3 Jun 2008 |
| LCT Presents Encapsulation Technology at Conference | Mon, 12 May 2008 |
| LCT Prepares to List on the International OTCQX | Thu, 8 May 2008 |
| LCT Diabetes Treatment to feature on Channel Ten News | Thu, 8 May 2008 |
| Appendix 4C - quarterly | Wed, 30 Apr 2008 |
| Change in substantial holding from AXA | Thu, 3 Apr 2008 |
| LCT Showcases Proprietary Nanobiocapsules at NZBio 2008 | Wed, 2 Apr 2008 |
| LCT Announces Compelling Results | Mon, 31 Mar 2008 |
| Change in substantial holding | Fri, 28 Mar 2008 |
| Change of Director`s Interest Notice | Thu, 20 Mar 2008 |
| Form 603/Form 605 | Thu, 20 Mar 2008 |
| LCT receives US $6million in Share Capital | Wed, 19 Mar 2008 |
| Appendix 3B | Wed, 19 Mar 2008 |
| LCT Cleansing Statement | Wed, 19 Mar 2008 |
| LCT ISSUED FOURTH US PATENT FOR DIABECELL | Mon, 17 Mar 2008 |
| Change of Director`s Interest Notice | Fri, 14 Mar 2008 |
| Results of General Meeting | Fri, 7 Mar 2008 |
| Half Yearly Report and Accounts | Fri, 29 Feb 2008 |
| LCT and US based Barbara Davis Center collaborate on trial | Wed, 27 Feb 2008 |
| LCT to Present Positive Preliminary Clinical Results | Wed, 13 Feb 2008 |
| Change of Director`s Interest Notice | Wed, 13 Feb 2008 |
| Diabetes Trial Supported By US-Based Diabetes Foundation | Tue, 12 Feb 2008 |
| LCT NOTICE OF GENERAL MEETING | Mon, 4 Feb 2008 |
| Appendix 3B and Cleansing Statement | Fri, 1 Feb 2008 |
| Appendix 4C - quarterly | Thu, 31 Jan 2008 |
| Becoming a substantial holder from AXA | Thu, 13 Dec 2007 |
| Appendix 3B | Wed, 5 Dec 2007 |
| Change of Director`s Interest Notice | Fri, 30 Nov 2007 |
| LCT Receives A$6.0 M In Capital Placement | Fri, 30 Nov 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.